Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results
Document Details
Form
Filing Date
Feb 7, 2019
Document Date
Jun 20, 2018
Form Description
An amendment to a 3 filing. Non-EDGAR filing
Filing Group
3,4,5
Company
Dianthus Therapeutics
Issuer
DIANTHUS THERAPEUTICS, INC. /DE/
Filer
COOKE MICHAEL P.